<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://investmentgems.net/2026/06/29/ligand-pharmaceuticals-the-bull-case-is-a-biotech-arm-the-bear-case-is-just-another-royalty-trust/</loc><news:news><news:publication><news:name>Investment Gems</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-29T20:06:08+00:00</news:publication_date><news:title>Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust</news:title></news:news><image:image><image:loc>https://investmentgems.net/wp-content/uploads/2020/02/4067287677_3f6356ca63_b.jpg?w=150</image:loc></image:image></url><url><loc>https://investmentgems.net/2026/06/29/biotech-is-the-rate-cut-trade-in-disguise/</loc><news:news><news:publication><news:name>Investment Gems</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-29T10:06:42+00:00</news:publication_date><news:title>Biotech Is the Rate-Cut Trade in Disguise</news:title></news:news><image:image><image:loc>https://investmentgems.net/wp-content/uploads/2023/08/pexels-photo-3938022.jpeg?w=150</image:loc></image:image></url></urlset>
